NCT03519958View on ClinicalTrials.gov

Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong Kong

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

September 30, 2018

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Non-small Cell Lung Cancer
Interventions
DIAGNOSTIC_TEST

Plasma-tissue testing

EGFR T790M mutation plasma-tissue testing in NSCLC patients who progressed on previous EGFR TKI

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY